BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38742843)

  • 1. Inflammasome-related gene signatures as prognostic biomarkers in osteosarcoma.
    Zhang N; Han Y; Cao H; Wang Q
    J Cell Mol Med; 2024 May; 28(9):e18286. PubMed ID: 38742843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of CD8 Tex cell-associated gene signatures in the prognosis and immunology of osteosarcoma.
    Lu Y; Cao N; Zhao M; Zhang G; Zhang Q; Wang L
    Sci Rep; 2024 Apr; 14(1):9769. PubMed ID: 38684858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma cancer.
    Liu R; Hu Y; Liu T; Wang Y
    BMC Cancer; 2021 Dec; 21(1):1345. PubMed ID: 34922489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Signature of Osteosarcoma Based on 14 Autophagy-Related Genes.
    Qi W; Yan Q; Lv M; Song D; Wang X; Tian K
    Pathol Oncol Res; 2021; 27():1609782. PubMed ID: 34335109
    [No Abstract]   [Full Text] [Related]  

  • 5. MAFB Promotes Cancer Stemness and Tumorigenesis in Osteosarcoma through a Sox9-Mediated Positive Feedback Loop.
    Chen Y; Wang T; Huang M; Liu Q; Hu C; Wang B; Han D; Chen C; Zhang J; Li Z; Liu C; Lei W; Chang Y; Wu M; Xiang D; Chen Y; Wang R; Huang W; Lei Z; Chu X
    Cancer Res; 2020 Jun; 80(12):2472-2483. PubMed ID: 32234710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
    Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
    BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an immune-related prognostic index associated with osteosarcoma.
    Yin CD; Hou YL; Liu XR; He YS; Wang XP; Li CJ; Tan XH; Liu J
    Bioengineered; 2021 Dec; 12(1):172-182. PubMed ID: 33371790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Hypoxia Gene-Based Signature to Predict the Survival and Affect the Tumor Immune Microenvironment of Osteosarcoma in Children.
    Jiang F; Miao XL; Zhang XT; Yan F; Mao Y; Wu CY; Zhou GP
    J Immunol Res; 2021; 2021():5523832. PubMed ID: 34337075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel six DNA damage response-related prognostic signature in osteosarcoma.
    Li T; Tang Z; Li S; Lu M
    Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):110-115. PubMed ID: 38650147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of immune-related genes as prognostic biomarkers for the assessment of osteosarcoma clinical outcomes.
    Guo J; Li X; Shen S; Wu X
    Sci Rep; 2021 Dec; 11(1):24123. PubMed ID: 34916564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLOD1 Is a Prognostic Biomarker and Mediator of Proliferation and Invasion in Osteosarcoma.
    Jiang H; Guo W; Yuan S; Song L
    Biomed Res Int; 2020; 2020():3418398. PubMed ID: 33134376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2.
    Wang Z; Tan M; Chen G; Li Z; Lu X
    IUBMB Life; 2017 Nov; 69(11):867-876. PubMed ID: 28960757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma.
    Wu G; Zhang M
    BMC Cancer; 2020 May; 20(1):456. PubMed ID: 32448271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Transcriptome Analysis Quantifies Immune Cell Transcript Levels, Metastatic Progression, and Survival in Osteosarcoma.
    Scott MC; Temiz NA; Sarver AE; LaRue RS; Rathe SK; Varshney J; Wolf NK; Moriarity BS; O'Brien TD; Spector LG; Largaespada DA; Modiano JF; Subramanian S; Sarver AL
    Cancer Res; 2018 Jan; 78(2):326-337. PubMed ID: 29066513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferroptosis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma.
    Lei T; Qian H; Lei P; Hu Y
    Cancer Sci; 2021 Nov; 112(11):4785-4798. PubMed ID: 34506683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LOXL1-AS1 predicts poor prognosis and promotes cell proliferation, migration, and invasion in osteosarcoma.
    Chen S; Li W; Guo A
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30944201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Four-Pseudogene Classifier Identified by Machine Learning Serves as a Novel Prognostic Marker for Survival of Osteosarcoma.
    Liu F; Xing L; Zhang X; Zhang X
    Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TYROBP, TLR4 and ITGAM regulated macrophages polarization and immune checkpoints expression in osteosarcoma.
    Liang T; Chen J; Xu G; Zhang Z; Xue J; Zeng H; Jiang J; Chen T; Qin Z; Li H; Ye Z; Nie Y; Liu C; Zhan X
    Sci Rep; 2021 Sep; 11(1):19315. PubMed ID: 34588497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of immune-related gene pairs signature to predict the overall survival of osteosarcoma patients.
    Li LQ; Zhang LH; Zhang Y; Lu XC; Zhang Y; Liu YK; Khader MA; Jia-Wen ; Tao-Liu ; Li JZ
    Aging (Albany NY); 2020 Nov; 12(22):22906-22926. PubMed ID: 33203792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-455-3p downregulation facilitates cell proliferation and invasion and predicts poor prognosis of osteosarcoma.
    Yi X; Wang Y; Xu S
    J Orthop Surg Res; 2020 Oct; 15(1):454. PubMed ID: 33008443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.